Cargando…
Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres
Infantile hemangioma (IH) is a benign pediatric tumor, and rapid growth of IH can result in serious morbidity and even mortality. Only one drug Hemangeol™ (propranolol hydrochloride oral solution) has been approved for the treatment of IH, whereas patients suffer from its adverse effects and high fr...
Autores principales: | Zhu, Xiaoshuang, Guo, Xiaonan, Liu, Dakan, Gong, Yubin, Sun, Jin, Dong, Changxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783591/ https://www.ncbi.nlm.nih.gov/pubmed/29192323 http://dx.doi.org/10.3892/or.2017.6103 |
Ejemplares similares
-
Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth
por: Guo, Xiaonan, et al.
Publicado: (2017) -
Management of Infantile Hemangiomas
por: Reddy, Kavitha K
Publicado: (2014) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Biology of Infantile Hemangioma
por: Itinteang, Tinte, et al.
Publicado: (2014) -
Approach to Infantile Hemangiomas
por: Abraham, Anil, et al.
Publicado: (2016)